Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q9H3R5
UPID:
CENPH_HUMAN
Alternative names:
Interphase centromere complex protein 35
Alternative UPACC:
Q9H3R5; A8K3Y1
Background:
Centromere protein H, also known as Interphase centromere complex protein 35, plays a pivotal role in chromosome segregation during cell division. It is a key component of the CENPA-NAC complex, essential for kinetochore protein assembly, mitotic progression, and accurate chromosome alignment on the metaphase plate.
Therapeutic significance:
Understanding the role of Centromere protein H could open doors to potential therapeutic strategies.